Resolve Therapeutics
Seattle, United States· Est.
Resolve Therapeutics combines RNases/DNases with antibody Fc domains to remove extracellular RNA/DNA and NETs, resolving inflammation across Sjögren’s, lupus, and critical care indications without suppressing immunity. Sjögren’s disease therapy.
Private Company
Total funding raised: $30M
About
Resolve Therapeutics combines RNases/DNases with antibody Fc domains to remove extracellular RNA/DNA and NETs, resolving inflammation across Sjögren’s, lupus, and critical care indications without suppressing immunity. Sjögren’s disease therapy.
Biologics
Funding History
2Total raised:$30M
Series A$25M
Seed$5M